GADAŞLI, İ. And CANSARAN DUMAN, D. 2023. Comparison of antibody and lobaric acid small molecule application in the treatment of ovarian cancer at the transcriptome level in the IL-6R / STAT3 / PD-L1 pathway.. 33rd International Symposium on Pharmaceutical and Biomedical Analysis. , (Turkey).

GADAŞLI, İ., & CANSARAN DUMAN, D., (2023). Comparison of antibody and lobaric acid small molecule application in the treatment of ovarian cancer at the transcriptome level in the IL-6R / STAT3 / PD-L1 pathway. . 33rd International Symposium on Pharmaceutical and Biomedical Analysis., Turkey

GADAŞLI, İBRAHİM, And DEMET CANSARAN DUMAN. "Comparison of antibody and lobaric acid small molecule application in the treatment of ovarian cancer at the transcriptome level in the IL-6R / STAT3 / PD-L1 pathway.," 33rd International Symposium on Pharmaceutical and Biomedical Analysis., Turkey, 2023

GADAŞLI, İBRAHİM And CANSARAN DUMAN, DEMET C. . "Comparison of antibody and lobaric acid small molecule application in the treatment of ovarian cancer at the transcriptome level in the IL-6R / STAT3 / PD-L1 pathway.." 33rd International Symposium on Pharmaceutical and Biomedical Analysis. , Turkey, 2023

GADAŞLI, İ. And CANSARAN DUMAN, D. (2023) . "Comparison of antibody and lobaric acid small molecule application in the treatment of ovarian cancer at the transcriptome level in the IL-6R / STAT3 / PD-L1 pathway.." 33rd International Symposium on Pharmaceutical and Biomedical Analysis. , Turkey.

@conferencepaper{conferencepaper, author={İBRAHİM GADAŞLI And author={DEMET CANSARAN DUMAN}, title={Comparison of antibody and lobaric acid small molecule application in the treatment of ovarian cancer at the transcriptome level in the IL-6R / STAT3 / PD-L1 pathway.}, congress name={33rd International Symposium on Pharmaceutical and Biomedical Analysis.}, city={}, country={Turkey}, year={2023}}